People: Bacterin International Holdings Inc (BONE.A)

Summary

Name	Age	Since	Current Position
Kent Swanson		2013	Independent Acting Chairman of the Board
John Gandolfo		2013	Interim Co-Chief Executive Officer, Chief Financial Officer
Darrel Holmes		2013	Interim Co-Chief Executive Officer, Chief Operating Officer
Nicholas Navarro	32	2012	National Sales Manager
John Deedrick		2012	Director
Mitchell Godfrey	66		Director
Michael Lopach	63		Independent Director
Jon Wickwire	68	2010	Independent Director

» Insider Trading

Biographies

Name	Description
Kent Swanson	Mr. Kent L. Swanson has been appointed as Independent Acting Chairman of the Board of Bacterin International Holdings, Inc., effective April 5, 2013. He was with Accenture for over 32 years, retiring from the firm in 2001 as a Senior Partner. He held global leadership and management positions in a wide range of industries and geographies. From 2001 to 2008, he was the Board Chair of ALN Medical Management; providing outsourced services for clinic-based physician practices. Also from 2001 to 2008, he was Board Chair for Boys Hope Girls Hope of Colorado, a charitable organization providing a home and scholarship education for disadvantaged children with capabilities and promise. From 2002 to 2009, he was a Board member, Audit Committee member and Compensation Committee Chair for MPC Computers. Mr. Swanson graduated with distinction from the University of Minnesota earning an M.S. in Business and received an M.B.A. from the University of Chicago in 1969. Mr. Swanson serves as chairman of the Board’s Compensation Committee.
John Gandolfo	Mr. John P. Gandolfo has been appointed as Interim Co-Chief Executive Officer, Chief Financial Officer of Bacterin International Holdings, Inc., effective April 5, 2013. He joined Bacterin as its interim Chief Financial Officer on a part-time basis, effective June 4, 2010, and filled this position full time commencing on July 6, 2010. Mr. Gandolfo has 25 years of experience as chief financial officer of rapidly growing private and publicly held companies with a primary focus in the life sciences, healthcare and medical device areas. Mr. Gandolfo has had direct responsibility over capital raising, including four public offerings, financial management, mergers and acquisition transactions and SEC reporting throughout his professional career. Prior to joining Bacterin, Mr. Gandolfo served as the Chief Financial Officer for Progenitor Cell Therapy LLC. Prior to joining Progenitor, Mr. Gandolfo served as the Chief Financial Officer for Power Medical Interventions, Inc., from January 2007 to January 2009. Prior to joining PMI, Mr. Gandolfo was the Chief Financial Officer of Bioject Medical Technologies, Inc., from September 2001 to May 2006, and served on the Bioject’s Board of Directors from September 2006 through May 2007. Prior to joining Bioject, Mr. Gandolfo was the Chief Financial Officer of Capital Access Network, Inc., from 2000 through September 2001, and Xceed, Inc., a publicly held Internet consulting firm, from 1999 to 2000. From 1994 to 1999, Mr. Gandolfo was Chief Financial Officer and Chief Operating Officer of Impath, Inc., a publicly held, cancer-focused healthcare information company. From 1987 through 1994, he was Chief Financial Officer of Medical Resources, Inc., a publicly held manager of diagnostic imaging centers throughout the United States. A graduate of Rutgers University, Mr. Gandolfo is a certified public accountant (inactive status) who began his professional career at Price Waterhouse.
Darrel Holmes	Mr. Darrel Lee Holmes has been appointed as Interim Co-Chief Executive Officer, Chief Operating Officer of Bacterin International Holdings, Inc., effective April 5, 2013. Mr. Holmes has over 25 years of experience in the medical device, biologics, and diagnostic industries. He previously served as Operations Executive for American Qualex, HYCOR Biomedical and Stratagene, and as Executive Vice President and COO of Big Spring Water Company. Since joining Bacterin International, Inc. in 2003, Mr. Holmes has assumed responsibilities for all aspects of medical device and biologic product design and development, process scale-up, and production. He is also responsible for the establishment and maintenance of an FDA CFR Title 21 Part 820 and 1271-compliant quality system. Mr. Holmes has worked with numerous regulatory agencies at the federal, state, and local level and coordinates Bacterin’s ISO 13485 compliance and environmental health and safety programs. He is the primary regulatory interface for Bacterin’s operations and he oversees production, facility management, engineering and information technology (IT) to produce Bacterin’s medical devices and biologic products, and to accommodate business growth. He directs the design, purchase, validation and implementation of capital assets and facility expansions for the company, and is responsible for strategic planning as well as the development and administration of division-level budgets. Currently, Mr. Holmes serves as the Tissue Bank Director and on Bacterin’s Medical Advisory Committee, as a member of Montana State University’s Employer Advisory Board, and as a Scientific Advisory Board Member for Montana Molecular in Bozeman, Montana. Mr. Holmes graduated from California State University at Long Beach with a degree in Biological Science.
Nicholas Navarro	Mr. Nicholas Maxwell Navarro serves as National Sales Manager of Bacterin International Holdings, Inc. He has eight years of sales and management experience in the orthopedic industry. As the National Sales Manager, Mr. Navarro is responsible for managing Bacterin’s hybrid distribution force by supporting product sales for all Bacterin divisions. Prior to being promoted to this position in February 2012, Mr. Navarro served in various roles at Bacterin, starting as a Direct Representative, advancing to a Regional Sales Manager, and relocating to headquarters to serve as Vice President of Devices. Mr. Navarro’s previous experience includes sales roles with Johnson and Johnson, specializing in wound and infection management, and at Wright Medical as a Foot and Ankle Hardware Specialist. Mr. Navarro has a Psychology degree from the University of Iowa and a minor in Business.
John Deedrick	Mr. John Deedrick has been appointed as Director of Bacterin International Holdings, Inc., effective September 6, 2012. Mr. Deedrick is an experienced senior executive with 15 years experience in healthcare venture capital and business consulting. Mr. Deedrick also has 12 years of experience in the high tech defense industry. He has served as a corporate venture capitalist for Mayo Clinic and a Founder and General Partner for Accuitive Medical Ventures. Mr. Deedrick also serves as President and CEO of CHIP Solutions and is Founder and Chairman of GreatDeeds, a Minnesota non-profit organization. Mr. Deedrick has served on the board of numerous early stage healthcare companies over the last 15 years. Mr. Deedrick received his undergraduate degree from Northwestern College (Roseville, MN) and his MBA from St. Thomas University (St. Paul, MN).
Mitchell Godfrey	Mr. Mitchell T. Godfrey serves as Director of Bacterin International Holdings, Inc. He has been involved over the past 25 years in a number of private enterprises, including consulting for and participation in firms in the manufacturing, medical devices, nuclear, service and animal health industries. Mr. Godfrey graduated from the University of Utah in 1968 with Bachelor of Science degrees in psychology and mathematics. He served as a Lieutenant in the U.S. Navy for a period of four years in the 1960s. Upon his return from overseas duty, he served as a director of the Utah Vietnam Agent Orange Program. He currently is the Chairman of the Montana based Crow Creek Falls Conservation Group and has been actively involved in many other organizations. Mr. Godfrey joined the Company in October 2003 as Chief Financial Officer until December 2007, when his primary responsibility was changed to investor relations. Mr. Godfrey currently serves as a consultant.
Michael Lopach	Mr. Michael A. Lopach serves as an Independent Director of Bacterin International Holdings, Inc. He is a certified public accountant with over 30 years of accounting experience. Mr. Lopach spent 27 years of his career with Galusha, Higgens, Galusha & Co., where he served as president and CEO. In 1999, Mr. Lopach founded Lopach & Carparelli PC, an accounting firm that focuses on medical practitioners. Mr. Lopach received his MBA from the University of Notre Dame. Mr. Lopach serves as chairman of the Board’s Audit Committee.
Jon Wickwire	Mr. Jon M. Wickwire serves as an Independent Director of Bacterin International Holdings, Inc. He is an attorney and founding shareholder of Wickwire Gavin, P.C., a national construction law firm which merged with Akerman Senterfitt. Mr. Wickwire served as lead counsel on infrastructure litigation and alternative dispute resolutions, both domestically and internationally, throughout his 35 year career, and was the founding fellow of the American College of Construction Lawyers. Mr. Wickwire also served as the founding chairman of the College of Scheduling, an organization dedicated to advancing the techniques, practice and profession of project scheduling, and has authored several books and articles on construction and public contract law, including Construction Management: Law and Practice and The Construction Subcontracting Manual: Practice Guide with Forms. Mr. Wickwire currently serves on the advisory board for Crunchies Food Company. Mr. Wickwire is a graduate of the University of Maryland and Georgetown University Law Center. Mr. Wickwire serves as chairman of the Nominations and Corporate Governance Committee.

Basic Compensation

Name	Fiscal Year Total
Kent Swanson	--
John Gandolfo	325,000
Darrel Holmes	162,692
Nicholas Navarro	--
John Deedrick	--
Mitchell Godfrey	--
Michael Lopach	--
Jon Wickwire	--

As Of 30 Dec 2011

Options Compensation

Name	Options	Value
Kent Swanson	0	0
John Gandolfo	0	0
Darrel Holmes	0	0
Nicholas Navarro	0	0
John Deedrick	0	0
Mitchell Godfrey	0	0
Michael Lopach	0	0
Jon Wickwire	0	0

Insider Trading

Name	Shares Traded	Price
COOK GUY S	5,000	$1.71
HOLMES DARREL LEE	15,000	$1.66
HOLMES DARREL LEE	15,000	$0.10
COOK GUY S	2,000,000	$0.00
COOK GUY S	6,000,000	$0.00
COOK GUY S	2,000,000	$0.00
COOK GUY S	2,000,000	$0.00
SWANSON KENT L	27,977	$1.40
COOK GUY S	20,000	$1.34
COOK GUY S	11,000	$1.30
SWANSON KENT L	800	$1.40
COOK GUY S	1,000,000	$0.00
COOK GUY S	4,500	$1.63
COOK GUY S	951	$1.58
COOK GUY S	5,000	$1.58
COOK GUY S	5,000	$1.62
COOK GUY S	2,500	$1.64
COOK GUY S	6,500	$1.67
COOK GUY S	10,000	$1.63
COOK GUY S	10,000	$1.68
COOK GUY S	10,000	$1.50
COOK GUY S	10,000	$1.57
COOK GUY S	10,000	$1.48
WICKWIRE JON M	20,000	$1.53
GODFREY MITCHELL	20,000	$2.75

» Full list on Insider Trading

People: Bacterin International Holdings Inc (BONE.A)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: